1,038 results found

his piece has been authored by Shambhavi Ravishankar, Associate, Ikigai Law, with inputs from Anirudh Rastogi, Founding and Managing Partner at Ikigai Law.

This case is important in the pharmaceutical patent context. Novartis had filed for a patent for the cancer drug Imatinib Mesylate in its beta crystalline form.

The legal dispute between the two pharmaceutical majors Gilead Sciences Inc. and Merck & Co. Inc. involving Hepatitis C drugs clearly indicates the high stakes involved when it comes to intellectual property.

Africa bears a very heavy burden of disease and its poor pharmaceutical manufacturing capacity forces it to rely heavily upon imports from other countries to fulfil its basic needs.

The imposition of damages in trademark infringement and passing off actions is common. Damages in the nature of punitive or exemplary damages in such cases are also common.

The taste of deceit in the food industry may come in various flavors including trademark/ brand dilution, substitution, concealment, unapproved enhancements, counterfeiting, mis-labelling and forgery.

With the steady increase in the volume of imports into India, the Government of India has introduced stricter standards to ensure compliance with quality standards in India.

Global drug manufacturers represented by the Organisation of Pharmaceutical Producers of India (OPPI) have sought ‘legislative review' of the section 3(d) of the Indian Patents Act and a redefining of the ‘efficacy criteria'.

‘Make in India' and ‘Made in India' have become popular issues in the recent times.

The FSSAI notified the Food Safety and Standards (Labelling and Display) Regulations, 2020 on November 17, 20201. The Regulations have notified a change in the display of nutritional information and calculation of nutrients for the pre-packaged products.

Corporate Social Responsibility (CSR) has been a soft law in most countries and is considered voluntary, self-regulated and beyond the scope of legislation.

This edition of the JSA Healthcare Newsletter focuses on key developments undertaken in the Indian healthcare ecosystem for the month of December.

The Indian medical device market is among the top 20 in the world and is expected to reach INR 794.29 billion by the end of 2023.

The origin of the modern statutory patent system is generally traced back to the Venetian Patent Statute of March 19, 1474 which stipulated...

On 24th February 2015, the Indian Patent office refused Bayer Healthcare AG'S attempt to patent tosylate salt form of its anticancer drug Sorafenib, known under the brand name Nexavar.

Patents are available only for inventions that are novel, non-obvious as well as useful. Therefore, where novelty is a bedrock concept of all patent systems, nonobviousness is the ultimate condition of patentability but first of all an invention i.e. a product of investigation and experiment must qualify as an invention.

The question whether cross examination is a discretionary remedy or a substantive right has come up before the Delhi High Court in context of post-grant oppositions filed against Novartis...

Having lived with the pandemic for more than a year now, it is important to recognize that while it has been a disruptive and challenging time for us, we haven't faced the brunt of it the way...